CD276 and neoplasm: To explore the role of C6orf120 in suppressing tumor immunity, we examined its association with inhibitory immune checkpoints (VISTA, CD96, TIGIT, CD47, CD200R, B7-H3, TNFRSF4, PD-1, PD-L1, and CTLA-4).